A new approach on assessing clinical pharmacists’ impact on prescribing errors in a surgical intensive care unit
Tóm tắt
Background With a clinical pharmacists’ participation in an intensive care unit (ICU) previous international studies have shown a reduction of medication errors, drug costs and improvements of clinical outcomes. Still there is a lack of qualitative data on clinical pharmacists’ impact on prescribing error rates in the ICU. Therefore, a new approach was developed relating prescribing errors to the number of monitored medications including physicians’ approval on all prescribing errors. Objective This study investigates the influence of clinical pharmacists’ medication review on the prescribing error rate in an ICU. Setting A controlled interventional study was conducted in a surgical ICU with one control phase (P0) and two intervention phases (P1 and P2). Method The investigation aimed to determine if the medication review by clinical pharmacists results in a significant reduction of prescribing errors related to a control period. In contrast to previous studies, prescribing errors detected by the clinical pharmacists, were only taken into account, if consent with the physicians was achieved. Secondary outcomes were the reduction of potentially severe prescribing errors, the number of days without systemic anti-infective therapy and the ICU length of stay. Throughout P0 the data was collected retrospectively without any intervention. During the intervention periods P1 and P2, two clinical pharmacists screened the medical records for prescribing errors and discussed them with the senior physician in charge. During P2 one clinical pharmacist attended ward rounds additionally. Main Outcome Measure The main outcome measure of this study was the number of prescribing errors detected related to the number of monitored medications. Results The incidence of prescribing errors was significantly reduced from 1660 in P0 to 622 in P1 respectively 401 in P2 (P0 vs. P1/P2 respectively; both p < 0.001; Fisher’s Exact Test) in total, respective 14.12% in P0 vs. 5.13% in P1 and 3.25% in P2 related to the monitored medications (P0:11755; P1:12134; P2:12329). Conclusion Clinical pharmacists’ interventions led to a significant reduction of prescribing errors in the ICU, contributing to a safer medication process. We strongly recommend a broad implementation of clinical pharmacists in ICUs.
Tài liệu tham khảo
Klopotowska JE, Kuiper R, van Kan HJ, de Pont A-C, Dijkgraaf MG, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.
Jiang S-P, Zheng X, Li X, Lu X-Y. Effectiveness of pharmaceutical care in an intensive care unit from China. A pre- and post-intervention study. Saudi Med J. 2012;33:756–62.
Leape LL, Cullen DJ, Clapp M, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.
Saokaew S, Maphanta S, Thangsomboon P. Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit. Pharm Pract. 2009;7:81–7.
Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med. 1994;22:1044–8.
Aljbouri TM, Alkhawaldeh MS, Abu-Rumman A, Eddeen K, Hasan TA, Khattar HM, et al. Impact of clinical pharmacist on cost of drug therapy in the ICU. Saudi Pharm J. 2013;21:371–4.
Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-Kholi TA, Akhras NS, Horanieh BK. The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Med J. 2008;29:277–81.
Kaushal R, Bates DW, Abramson EL, Soukup JR, Goldmann DA. Unit-based clinical pharmacists’ prevention of serious medication errors in pediatric inpatients. Am J Health Syst Pharm. 2008;65:1254–60.
Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacother J Hum Pharmacol Drug Ther. 2007;27:481–93.
MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically Ill patients with thromboembolic or infarction-related events. Pharmacother J Hum Pharmacol Drug Ther. 2009;29:761–8.
Langebrake C, Ihbe-Heffinger A, Leichenberg K, Kaden S, Kunkel M, Lueb M, et al. Nationwide evaluation of day-to-day clinical pharmacists’ interventions in German hospitals. Pharmacotherapy. 2015;35:370–9.
Bertsche T, Pfaff J, Schiller P, Kaltschmidt J, Pruszydlo MG, Stremmel W, et al. Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. Intensive Care Med. 2010;36:665–72.
Langebrake C, Hilgarth H. Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci PWS. 2010;32:194–9.
Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics. 1978;34:483–6.
MacLaren R, Brett McQueen R, Campbell J. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. Pharmacotherapy. 2013;33:401–10.
Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5:8.
Johansen ET, Haustreis SM, Mowinckel AS, Ytrebø LM. Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU. Eur J Hosp Pharm. 2016;23:197–202.
Claus BOM, Robays H, Decruyenaere J, Annemans L. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups. J Eval Clin Pract. 2014;20:1172–9.
Weber A, Schneider C, Grill E, Strobl R, Vetter-Kerkhoff C, Jauch K-W. Interventionen eines apothekers auf chirurgischen normalstationen—auswirkungen auf die antibiotikatherapie. Zentralblatt Chir. 2011;136:66–73.
Wegermann P, Feine C, Tryba M. Stress-ulcer prophylaxis in mechanically ventilated patients: does dosage matter? Intensive Care Med. 2001;27:S267.